Pharmanutra

What Pharmanutra does

PharmaNutra S.p.A. is an Italian pharmaceutical company founded in 2003 by brothers Andrea and Roberto Lacorte, headquartered in Pisa and publicly listed on Borsa Italiana under ticker BIT:PHN. The company researches, develops, manufactures, and commercializes nutraceutical food supplements and Class IIA medical devices, with clinical focus on mineral and vitamin deficiencies (especially iron deficiency), musculoskeletal health, and sports nutrition. Its technological foundation is built on two proprietary pillars: the patented Sucrosomial Technology — a phospholipid- and sucrose-ester-based delivery system that protects micronutrients through the gastric environment and enables intestinal absorption — and Cetylated Fatty Acids (CFA) formulations for joint and muscle support. The company holds 22 proprietary raw materials, 25 registered patents, 55 registered trademarks, and an evidence base of 191 clinical studies, manufactured at a 2,200+ sqm production facility in Pisa that includes one of Europe's more advanced nutritional R&D laboratories.

The business model is hybrid. PharmaNutra generates revenue from finished consumer nutraceuticals sold under multiple sub-brands (SiderAL, Cetilar, Apportal, Sidevit, UltraMag, Lactopam, Bonecal, Novomega, Cetilar Nutrition) through pharmacy channels, six proprietary e-commerce platforms, and online marketplaces such as Amazon — reaching consumers in over 85 countries. A separate B2B arm, Pharmanutra Ingredients (launched at Vitafoods Europe 2025), sells proprietary and partner functional ingredients to nutraceutical, food, and pharmaceutical manufacturers, supported by partner distribution agreements with DSM, Marigot Ltd, and Ingredia Nutritional. The go-to-market is sales-led, anchored in scientific engagement with healthcare professionals (doctors, pharmacists, physiotherapists), reinforced by content marketing, university research collaborations (La Sapienza Rome, University of Brescia, University of Pisa, Fondazione Andrologica pediatrica), and presence at international congresses (CPHI Worldwide, IMCID, Spazio Nutrizione, SANIS).

Customer segments span patients with iron/vitamin deficiencies, patients with musculoskeletal conditions, athletes and women's health populations on the B2C side, and nutraceutical/pharmaceutical manufacturers on the B2B side. Regulatory credentials include CE Mark for Class IIA medical devices, FDA GMP (CFR Title 21, Part 111), ISO 9001, SA 8000, Halal, Kosher, and Play Sure Doping Free certifications; Sucrosomial Iron is recognized in WHO guidelines. In July 2024, PharmaNutra completed a merger with Alesco, integrating an Italian food supplements business unit into the Group.

Name

Pharmanutra

Legal name

PharmaNutra S.p.A.

Website

https://pharmanutra.it

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmanutra S.p.A. is an Italian nutraceutical and medical device company founded in 2003 that develops proprietary Sucrosomial and Cetylated Fatty Acid formulations for mineral deficiencies, musculoskeletal health, and sports nutrition, distributing branded consumer products and B2B functional ingredients across 85+ countries.

Ownership category

akta.pro rank

Product category

Nutraceutical Supplements and Medical Devices

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Food And Kindred Products (2000), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Vitamins & Minerals (Single Nutrients) (CRADAGAB)

akta.pro secondary industries

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Multivitamins & Daily Packs (CRADAGAC), Vitamins (A, B-Complex, C, D, E, K; Premixes) (AFAJAKAA), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Nutraceutical supplements
• Iron deficiency supplements
• Medical devices
• Functional food ingredients
• Musculoskeletal health products

Headquarters

HQ city

Pisa

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Food Supplements: Sale of dietary supplements under brand names including SiderAL (iron supplements), Apportal (multinutrient supplements), Sidevit (vitamin D3 and B12), UltraMag (magnesium), Lactopam (sleep support), Cetilar Nutrition (sports nutrition products), Novomega (omega-3), and Bonecal (bone health). Products sold through pharmacies, direct-to-consumer e-commerce, and online marketplaces.
2. Medical Devices: Sale of medical devices including Blefarene Care (eye hygiene wipes), DoloMir Oto (ear solution), DoloMir Gola (throat spray), and Celadrin (topical cream). These products carry CE Mark certification for Class IIA medical devices.
3. B2B Ingredients (Pharmanutra Ingredients): Sale of proprietary functional ingredients to other nutraceutical, food, and pharmaceutical companies. Includes exclusive distribution of international partner ingredients (DSM, Marigot Ltd, Ingredia Nutritional) in Italy. Offers scientific and regulatory expertise, technical documentation, and formulation support to customers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

PharmaNutra researches, develops, manufactures and commercializes proprietary nutraceutical food supplements and CE-marked Class IIA medical devices. Finished consumer products are sold under brands such as SiderAL (iron), Apportal (multinutrients), Sidevit (vitamins D3/B12), UltraMag (magnesium), Lactopam (sleep), Cetilar (topical/oral CFA for joints and muscles), Bonecal and Novomega. The Pharmanutra Ingredients B2B division sells 22 proprietary functional ingredients and exclusive Italian distribution rights for DSM, Marigot, and Ingredia ingredients to other nutraceutical, food, and medical food manufacturers.

Differentiator

Problem solved

Functional benefit

Brands

• SiderAL: Iron supplement brand featuring Sucrosomial Iron technology for iron deficiency treatment
• Cetilar
• Apportal
• Sidevit
• Ultramag
• Lactopam
• Pharmanutra Ingredients
• Cetilar Nutrition

Products and services

• SiderAL Sucrosomial Iron dietary supplement for iron deficiency management, sold through pharmacies, own e-commerce and Amazon, with better gastrointestinal tolerability than conventional iron supplements.
• Apportal Complete multinutrient supplement brand providing 19+ nutrients including Sucrosomial minerals, vitamins, and amino acids for general nutritional support.
• Sidevit B12 Orodispersible Vitamin B12 supplement using Sucrosomial Technology and Quatrefolic, designed for B12 deficiency support.
• Sidevit Vitamin supplement brand using Sucrosomial Technology for Vitamin D3 and B12 products.
• UltraMag Magnesium supplement using Sucrosomial Technology delivering 100% NRV in a single dose.
• Lactopam Supplement combining Lactium and Sucrosomial Magnesium for relaxation and sleep support.
• Cetilar r.m. Topical Cetylated Fatty Acids (CFA) formulation at 7.5% concentration for joint and muscle mobility support, available through pharmacies and direct e-commerce.
• Lipocet Oral Cetylated Fatty Acids (CFA) supplement for joint and muscle wellness, classified as a novel food from 2022.
• Cetilar Nutrition Sports nutrition product line including energy gels, carb drinks, recovery supplements and protein bars, carrying the Play Sure Doping Free seal.
• Bonecal Dietary supplement for bone health support.
• Novomega Omega-3 dietary supplement.
• Blefarene Care CE-marked Class IIA medical device: eye hygiene wipes.
• DoloMir Oto CE-marked Class IIA medical device: ear care solution.
• DoloMir Gola CE-marked Class IIA medical device: throat spray.
• Celadrin Topical cream for joint and muscle support.
• Pharmanutra Ingredients (B2B Functional Ingredients) B2B portfolio of 22 proprietary functional ingredients (Sucrosomial minerals and bioactives: Sidemag, UltraCal, UltraChrome, UltraIod, UltraSel, UltraB12, UltraD3, Ultrazin, UltraRed, UltraMir, UltraJoint, UltraSterol) plus exclusive Italian distribution of international partner ingredients, sold to nutraceutical, food and pharmaceutical manufacturers with FDA GMP, Halal and Kosher certification.
• Bimuno GOS Prebiotic Clinically studied galacto-oligosaccharide (GOS) prebiotic distributed in Italy by PharmaNutra Ingredients under partnership with Ingredia Nutritional, effective at low doses.

Quantifiable outcome

• Sucrosomial Iron is the only fast, safe, and well-tolerated oral formulation for addressing mineral and vitamin deficiencies
• +1 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• La Sapienza University of RomecoreStrategic or Co-development PartnerScientific collaboration for nutraceutical and pharmaceutical research. The university has participated in multiple research projects advancing the understanding of Sucrosomial Technology applications and nutritional supplementation efficacy.
• University of BresciacoreStrategic or Co-development PartnerCollaborative research partner in nutritional science and nutraceutical development, contributing to clinical evidence generation for company products.
• University of PisacoreStrategic or Co-development PartnerAcademic research partner supporting molecular biology research and nutraceutical technology development. The company plans to make its molecular biology laboratories available to partner universities for new studies.
• Fondazione Andrologica pediatrica e dell'adolescenzacoreStrategic or Co-development PartnerPediatric and adolescent andrology foundation collaborating on research related to pediatric nutritional needs and supplementation.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Thorne HealthTech: U.S. premium supplements company focused on clinical-grade nutritional products backed by scientific research and sold via DTC and practitioner channels. Comparable as a science-led, premium-positioned nutraceutical with practitioner recommendation model and direct e-commerce distribution analogous to PharmaNutra's B2C model.
• BioGaia: Swedish probiotics and gut-health company built on strong clinical evidence and proprietary probiotic strains sold globally. Comparable as a clinical-evidence-led, premium nutraceutical with global distribution via pharmacy and DTC channels, focused on microbiome and specialty conditions.
• Labomar: Italian nutraceutical CDMO and branded supplements company listed on Euronext Growth Milan. Comparable as a fellow Italian nutraceutical with proprietary formulations, contract manufacturing capability, and branded consumer supplements in similar therapeutic categories.
• Aboca: Italian herbal medicine and nutraceutical manufacturer selling clinically validated natural health products through pharmacy channels across Europe. Highly comparable as an Italian-rooted, science-led nutraceutical with similar product categories (digestive, joint, women's health) and pharmacy-led distribution.
• Alfasigma: Italian pharmaceutical group with a meaningful nutraceutical and consumer health portfolio alongside prescription drugs. Comparable as a domestically-rooted Italian pharma-nutraceutical hybrid with overlapping therapeutic areas (gastrointestinal, joint health, women's health) and similar pharmacy channel strategy.

Emerging players

• Gnosis by Lesaffre: B2B manufacturer of nutraceutical and functional ingredients (S-adenosylmethionine, probiotics, vitamins) backed by Lesaffre's fermentation platform. Comparable as a science-backed functional ingredient supplier competing in the same B2B space as PharmaNutra Ingredients.

Broad incumbents

• IBSA Farmaceutici: Swiss-Italian pharmaceutical group with a strong consumer health and nutraceutical portfolio including fertility, thyroid, and joint health categories. Comparable as a broader pharma-nutraceutical incumbent with overlapping women's health, endocrine, and musculoskeletal focus areas.
• dsm-firmenich: Global nutrition, health, and ingredients giant with a substantial nutraceutical ingredient portfolio including vitamins, minerals, and functional bioactives. Directly comparable as a B2B functional ingredients supplier to nutraceutical and food manufacturers — competing head-to-head with PharmaNutra Ingredients.
• Chiesi Farmaceutici: Major privately-held Italian pharmaceutical company with global reach across respiratory, neonatology, and rare diseases, plus consumer health extensions. Comparable as an established Italian pharma incumbent with international footprint overlapping PharmaNutra's clinical evidence-driven model.
• Recordati: Large Italian pharmaceutical group with operations across rare diseases, specialty pharma, and consumer health. Comparable as a broader Italian pharma incumbent whose consumer health segment overlaps PharmaNutra's therapeutic categories and Italian/European pharmacy channel presence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCA-ecn6Crd4Y4_UmQ7w0xog
• Facebookfacebook.com/pharmanutra
• LinkedInlinkedin.com/company/pharmanutra
• Instagraminstagram.com/pharmanutra_spa

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmanutra